Today’s stock market highlights underscore significant developments across various sectors, particularly in pharmaceuticals, technology, and consumer goods. Here are the key events shaping the market:
- Regeneron Pharmaceuticals and Sanofi received a three-month extension from the U.S. FDA for their priority review of Dupixent for treating COPD patients, now due by September 27, 2024. This follows additional efficacy analyses requested by the FDA. Read More
- STMicroelectronics is set to establish the world’s first fully integrated silicon carbide facility in Italy with a €5 billion investment aimed at supporting automotive electrification. Production is expected to start in 2026. Read More
- Gilead Sciences presented results from its Phase 3 EVOKE-01 study at the ASCO 2024 meeting. Although the study did not meet its primary endpoint, it showed a 16% reduction in mortality risk with Trodelvy compared to docetaxel. Read More
- Moderna received FDA approval for its mRNA RSV vaccine, mRESVIA, targeting adults aged 60 and older. The vaccine showed an efficacy of 83.7% in trials. Plans for rollout in the U.S. are set for the 2024/2025 respiratory season. Read More
- UBS finalized its merger with Credit Suisse, creating a single entity as Credit Suisse is deregistered. This completion is expected to unlock cost and capital benefits moving forward. Read More
- Ionis Pharmaceuticals released positive Phase 3 results for its investigational drug donidalorsen, which showed >90% reduction in hereditary angioedema attacks, enhancing its potential for regulatory approval. Read More
- Walmart is expanding its InHome delivery service to an additional 10 million U.S. households, now reaching over 45 million homes. The service delivers groceries directly into customer kitchens, enhancing convenience. Read More
- Flutter Entertainment has completed its transition to a primary listing on the NYSE, reflecting its strategic focus on the U.S. sports betting market. Read More
These pivotal updates reflect ongoing market dynamics and investor sentiments as companies push for growth, innovation, and compliance with regulatory standards.
